Merus N.V. 3 SEC Filings

Filed On	Filing
18 Dec 2025	Form 3: Genmab A/S, 10% owner Holds 71,463,077 shares of Common Shares, nominal value EUR 0.09 per share
03 Jul 2024	Form 3: Zohren Fabian, Chief Medical Officer No securities owned
09 May 2024	Form 3: Haddock Jason, Director No securities owned
02 Jun 2021	Form 3: Gowen Maxine, Director
06 May 2021	Form 3: Geuijen Cecile A W, SVP & Chief Scientific Officer
05 Aug 2020	Form 3: Joe Andrew, SVP, CMO No securities owned
02 Jul 2020	Form 3: Pucci Paolo, Director No securities owned
03 Jun 2020	Form 3: Bvf Gp Holdings Llc, 10% owner and 2 others Holds 1,804,105 shares of Common Shares, (euro)0.09 nominal value per share
13 Jan 2020	Form 3: Bvf Partners L P/IL, 10% owner and 6 others Holds 1,604,215 shares of Common Shares, (euro)0.09 nominal value per share
02 Jan 2020	Form 3: Perry Gregory D, Director
02 Jan 2020	Form 3: Kanavy Len, Director
02 Jan 2020	Form 3: Liu Hui, EVP, CBO & Head of Merus US Holds 30,000 shares of Common Shares
02 Jan 2020	Form 3: de Kruif John, SVP & Chief Technology Officer Holds 10,537 shares of Common Shares
02 Jan 2020	Form 3: Sandor Victor, Director
02 Jan 2020	Form 3: Silverman Peter B., EVP & General Counsel
02 Jan 2020	Form 3: Mehra Anand, Director Holds 1,961,039 shares of Common Shares
02 Jan 2020	Form 3: Iwicki Mark T, Director
02 Jan 2020	Form 3: Throsby Mark, EVP & Chief Scientific Officer Holds 4,078 shares of Common Shares
02 Jan 2020	Form 3: Lundberg Sven Ante, Director Holds 37,495 shares of Common Shares
02 Jan 2020	Form 3: Greig Russell, Director

Comments